African animal trypanocide resistance: A systematic review and meta-analysis

Background: African animal trypanocide resistance (AATr) continues to undermine global efforts to eliminate the transmission of African trypanosomiasis in endemic communities. The continued lack of new trypanocides has precipitated drug misuse and overuse, thus contributing to the development of...

Full description

Saved in:
Bibliographic Details
Main Authors: Keneth Iceland, Kasozi, Ewan, Thomas MacLeod, Susan, Christina Welburn
Format: Article
Language:English
Published: Frontiers in Veterinary Science 2023
Subjects:
Online Access:http://hdl.handle.net/20.500.12493/1144
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1800403077794103296
author Keneth Iceland, Kasozi
Ewan, Thomas MacLeod
Susan, Christina Welburn
author_facet Keneth Iceland, Kasozi
Ewan, Thomas MacLeod
Susan, Christina Welburn
author_sort Keneth Iceland, Kasozi
collection KAB-DR
description Background: African animal trypanocide resistance (AATr) continues to undermine global efforts to eliminate the transmission of African trypanosomiasis in endemic communities. The continued lack of new trypanocides has precipitated drug misuse and overuse, thus contributing to the development of the AATr phenotype. In this study, we investigated the threat associated with AATr by using the major globally available chemotherapeutical agents. Methods: A total of seven electronic databases were screened for an article on trypanocide resistance in AATr by using keywords on preclinical and clinical trials with the number of animals with treatment relapse, days taken to relapse, and resistant gene markers using the PRISMA checklist. Data were cleaned using the SR deduplicator and covidence and analyzed using Cochrane RevMan®. Dichotomous outputs were presented using risk ratio (RR), while continuous data were presented using the standardized mean difference (SMD) at a 95% confidence interval. Results: A total of eight publications in which diminazene aceturate (DA), isometamidium chloride (ISM), and homidium chloride/bromide (HB) were identified as the major trypanocides were used. In all preclinical studies, the development of resistance was in the order of HB > ISM > DA. DA vs. ISM (SMD = 0.15, 95% CI: −0.54, 0.83; I2 = 46%, P = 0.05), DA vs. HB (SMD = 0.96, 95% CI: 0.47, 1.45; I2 = 0%, P = 0.86), and HB vs. ISM (SMD = −0.41, 95% CI: −0.96, 0.14; I2 = 5%, P = 0.38) showed multiple cross-resistance. Clinical studies also showed evidence of multi-drug resistance on DA and ISM (RR = 1.01, 95% CI: 0.71–1.43; I2 = 46%, P = 0.16). To address resistance, most preclinical studies increased the dosage and the treatment time, and this failed to improve the patient’s prognosis. Major markers of resistance explored include TbAT1, P1/P2 transporters, folate transporters, such as F-I, F-II, F-III, and polyamine biosynthesis inhibitors. In addition, immunosuppressed hosts favor the development of AATr. Conclusion: AATr is a threat that requires a shift in the current disease control strategies in most developing nations due to inter-species transmission. Multi- drug cross-resistance against the only accessible trypanocides is a major publichealth risk, justifying the need to revise the policy in developing countries to promote control of African trypanosomiasis
format Article
id oai:idr.kab.ac.ug:20.500.12493-1144
institution KAB-DR
language English
publishDate 2023
publisher Frontiers in Veterinary Science
record_format dspace
spelling oai:idr.kab.ac.ug:20.500.12493-11442024-01-17T04:48:37Z African animal trypanocide resistance: A systematic review and meta-analysis Keneth Iceland, Kasozi Ewan, Thomas MacLeod Susan, Christina Welburn African animal trypanosomiasis Trypanosoma brucei brucei Trypanocide resistance Drug resistance T. evansi T. congolense T. vivax Bovine trypanosomiasis Background: African animal trypanocide resistance (AATr) continues to undermine global efforts to eliminate the transmission of African trypanosomiasis in endemic communities. The continued lack of new trypanocides has precipitated drug misuse and overuse, thus contributing to the development of the AATr phenotype. In this study, we investigated the threat associated with AATr by using the major globally available chemotherapeutical agents. Methods: A total of seven electronic databases were screened for an article on trypanocide resistance in AATr by using keywords on preclinical and clinical trials with the number of animals with treatment relapse, days taken to relapse, and resistant gene markers using the PRISMA checklist. Data were cleaned using the SR deduplicator and covidence and analyzed using Cochrane RevMan®. Dichotomous outputs were presented using risk ratio (RR), while continuous data were presented using the standardized mean difference (SMD) at a 95% confidence interval. Results: A total of eight publications in which diminazene aceturate (DA), isometamidium chloride (ISM), and homidium chloride/bromide (HB) were identified as the major trypanocides were used. In all preclinical studies, the development of resistance was in the order of HB > ISM > DA. DA vs. ISM (SMD = 0.15, 95% CI: −0.54, 0.83; I2 = 46%, P = 0.05), DA vs. HB (SMD = 0.96, 95% CI: 0.47, 1.45; I2 = 0%, P = 0.86), and HB vs. ISM (SMD = −0.41, 95% CI: −0.96, 0.14; I2 = 5%, P = 0.38) showed multiple cross-resistance. Clinical studies also showed evidence of multi-drug resistance on DA and ISM (RR = 1.01, 95% CI: 0.71–1.43; I2 = 46%, P = 0.16). To address resistance, most preclinical studies increased the dosage and the treatment time, and this failed to improve the patient’s prognosis. Major markers of resistance explored include TbAT1, P1/P2 transporters, folate transporters, such as F-I, F-II, F-III, and polyamine biosynthesis inhibitors. In addition, immunosuppressed hosts favor the development of AATr. Conclusion: AATr is a threat that requires a shift in the current disease control strategies in most developing nations due to inter-species transmission. Multi- drug cross-resistance against the only accessible trypanocides is a major publichealth risk, justifying the need to revise the policy in developing countries to promote control of African trypanosomiasis Kabale University 2023-04-20T13:08:08Z 2023-04-20T13:08:08Z 2023-01-04 Article http://hdl.handle.net/20.500.12493/1144 en Attribution-NonCommercial-NoDerivs 3.0 United States http://creativecommons.org/licenses/by-nc-nd/3.0/us/ application/pdf Frontiers in Veterinary Science
spellingShingle African animal trypanosomiasis
Trypanosoma brucei brucei
Trypanocide resistance
Drug resistance
T. evansi
T. congolense
T. vivax
Bovine trypanosomiasis
Keneth Iceland, Kasozi
Ewan, Thomas MacLeod
Susan, Christina Welburn
African animal trypanocide resistance: A systematic review and meta-analysis
title African animal trypanocide resistance: A systematic review and meta-analysis
title_full African animal trypanocide resistance: A systematic review and meta-analysis
title_fullStr African animal trypanocide resistance: A systematic review and meta-analysis
title_full_unstemmed African animal trypanocide resistance: A systematic review and meta-analysis
title_short African animal trypanocide resistance: A systematic review and meta-analysis
title_sort african animal trypanocide resistance a systematic review and meta analysis
topic African animal trypanosomiasis
Trypanosoma brucei brucei
Trypanocide resistance
Drug resistance
T. evansi
T. congolense
T. vivax
Bovine trypanosomiasis
url http://hdl.handle.net/20.500.12493/1144
work_keys_str_mv AT kenethicelandkasozi africananimaltrypanocideresistanceasystematicreviewandmetaanalysis
AT ewanthomasmacleod africananimaltrypanocideresistanceasystematicreviewandmetaanalysis
AT susanchristinawelburn africananimaltrypanocideresistanceasystematicreviewandmetaanalysis